Hepatic a Typical PKC: A Novel Target for Newlydevelpoed Inhibitors that Reverse Obesity and Metabolic Syndrome and Diabetic Characteristics and Features in Human Hepatocytes and a Murine Obesity/Diabetes Model
Aims/Hypothesis:We tested the role of the hepatic protein kinase C- ι (PKC- ι ) in mediating metabolic abnormalities in type 2 diabetes mellitus (T2DM) with novel PKC- ι inhibitors ... hepatocytes of T2DM humans, and…

